Investigations of apoC-III metabolism using stable isotopes: What information can you acquire and how can you interpret your results?

Journal of Lipid Research

Volumn 52, Issue 6, 2011, Pages 1071-1072

  Ginsberg, Henry N ^a   Ramakrishnan, Rajasekhar ^a  

^a Columbia University College of Physicians and Surgeons ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN A1; APOLIPOPROTEIN B; APOLIPOPROTEIN C3; HIGH DENSITY LIPOPROTEIN; VERY LOW DENSITY LIPOPROTEIN;

DISEASE COURSE; DYSLIPIDEMIA; HUMAN; LIPOPROTEIN BLOOD LEVEL; LIPOPROTEIN METABOLISM; NONHUMAN; NOTE; PATHOPHYSIOLOGY; PLASMA CLEARANCE; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; PROTEIN TRANSPORT;

APOLIPOPROTEIN C-III; APOLIPOPROTEINS B; CASE-CONTROL STUDIES; FEMALE; HUMANS; ISOTOPE LABELING; KIDNEY; KIDNEY FAILURE, CHRONIC; LIPID METABOLISM; LIPOPROTEINS, HDL; LIPOPROTEINS, IDL; LIPOPROTEINS, VLDL; LIVER; MALE; MENTAL PROCESSES; MIDDLE AGED; STATISTICS AS TOPIC; TRIGLYCERIDES;

EID: 79956015833     PISSN: 00222275     EISSN: 15397262     Source Type: Journal    
DOI: 10.1194/jlr.E015958     Document Type: Note

References (12)

1. Alaupovic, P. 1991. Apolipoprotein composition as the basis for classifying plasma lipoproteins. Characterization of Apo-A-and ApoB-containing lipoprotein families. Prog. Lipid Res. 30: 105-138. (Pubitemid 121002991)
2. Tomiyasu, K., B. W. Walsh, K. Ikewaki, H. Judge, and F. M. Sacks. 2001. Differential metabolism of human VLDL according to content of ApoE and Apo-C-III. Arterioscler. Thromb. Vasc. Biol. 21: 1494-1500.
3. Zheng, C., C. Khoo, J. Furtado, and F. M. Sacks. 2010. Apolipoprotein C-III and the metabolic basis for hypertriglyceridemia and the dense low-density lipoprotein phenotype. Circulation. 121: 1722-1734.
4. Mendivil, C. O., C. Zheng, J. Furtado, J. Lei, and F. M. Sacks. 2010. Metabolism of very-low density lipoprotein and low-density lipoprotein containing apolipoprotien C-III and not other small apolipoproteins. Arterioscler. Thromb. Vasc. Biol. 30: 239-245.
5. Kawakami, A., and M. Yoshida. 2009. Apolipoprotein CIII links dyslipidemia with atherosclerosis. J. Atheroscler. Thromb. 16: 6-11.
6. Ginsberg, H. N., and W. V. Brown. 2011. Apolipoprotein CIII: 42 years old and even more interesting. Arterioscler. Thromb. Vasc. Biol. 31: 471-473.
7. Ooi, E. M. M., D. T. Chan, G. F. Watts, D. C. Chan, T. W. K. Ng, G. K. Dogra, A. B. Irish, and P. H. R. Barrett. 2011. Plasma apoliprotein C-III metabolism in patients with chronic kidney disease. J. Lipid Res. 52: 794-800.
8. Shimomura, I., M. Matsuda, R. E. Hammer, Y. Bashmakov, M. S. Brown, and J. L. Goldstein, 2000. Decreased IRS-2 and increased SREBP-1c lead to mixed insulin resistance and sensitivity in livers of lipodystrophic and ob/ob mice. Mol. Cell. 6: 77-86.
9. Chan, D. C., M. N. Nguyen, G. F. Watts, and P. H. Barrett. 2008. Plasma apolipoprotein C-III transport in centrally obese men: associations with very low-density lipoprotein apolipoprotein B and high-density lipoprotein apolipoprotein A-I metabolism. J. Clin. Endocrinol. Metab. 93: 557-564.
10. Ginsberg, H. N., and R. Ramakrishnan. 2008. Kinetic studies of the metabolism of rapidly exchangeable apolipoproteins may leave investigators and readers with exchangeable results. Arterioscler. Thromb. Vasc. Biol. 28: 1685-1686.
11. Nguyen, M. N., D. C. Chan, K. P. Dwyer, P. Bolitho, G. F. Watts, and P. H. Barrett. 2006. Use of intralipid for kinetic analysis of HDL apoC-III: evidence for a homogeneous kinetic pool of apoC-III in plasma. J. Lipid Res. 47: 1274-1280.
12. Batal, R., M. Tremblay, P. H. R. Barrett, H. Jacques, A. Fredenrich, O. Mamer, J. Davignon, and J. S. Cohn. 2000. Plasma kinetics of apoC-III and apoE in normolipidemic and hypertriglyceridemic subjects. J. Lipid Res. 41: 706-718.